Capital International Sarl’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-48,115
Closed -$3.86M 150
2016
Q4
$3.86M Sell
48,115
-10,200
-17% -$810K 0.35% 83
2016
Q3
$4.65M Sell
58,315
-14,200
-20% -$1.15M 0.39% 78
2016
Q2
$5.66M Sell
72,515
-9,600
-12% -$685K 0.48% 72
2016
Q1
$4.52M Sell
82,115
-20,200
-20% -$1.1M 0.38% 79
2015
Q4
$6.32M Sell
102,315
-77,940
-43% -$4.92M 0.53% 65
2015
Q3
$11.4M Hold
180,255
1.02% 32
2015
Q2
$13.2M Buy
180,255
+58,165
+48% +$4.2M 0.98% 37
2015
Q1
$7.99M Sell
122,090
-15,100
-11% -$1M 0.58% 62
2014
Q4
$8.92M Buy
137,190
+134,490
+4,981% +$8.66M 0.55% 64
2014
Q3
$162K Buy
2,700
+600
+29% +$39.2K 0.01% 145
2014
Q2
$145K Buy
+2,100
New +$136K 0.01% 145

Other funds holding STJ

Capital International Sarl's STJ Position: Q1 2017 in Review

Capital International Sarl sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 48,115 shares — an estimated $3.86M sold.

Capital International Sarl first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $13.2M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Capital International Sarl reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Capital International Sarl sold 48,115 St Jude Medical shares in Q1 2017, an estimated $3.86M.
  • Capital International Sarl first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Capital International Sarl's St Jude Medical position peaked at $13.2M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Capital International Sarl's 13F filing for Q1 2017, filed 15 May 2017.